Brief: Lipocine To Present Clinical Data On Lpcn 1148 At The Liver Meeting® 2023
01/11/2023 12:05
Nov 1 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE TO PRESENT CLINICAL DATA ON LPCN 1148 AT THE
LIVER
MEETING® 2023
Source text for Eikon: ID:nPncdBjVqa
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy